Learn, Analyse & Invest
only with
only with
+91
Download Orca
Beryl Drugs Ltd.
Beryl Drugs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹11.06 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 11 08 2021 | Quarterly Results |
| 03 09 2021 | Inter alia, to consider and approve : 1. to approve the Board report of the Company; 2. to fix the date and approve notice of the 28th Annual General Meeting of the Company; 3. to fix the dates of the Annual Book Closure of the Company for the 28th Annual General Meeting; 4. fix the Cut-off Date and Remote E-voting period for the Ensuing AGM; 5. to appoint Scrutinizer for the purpose of remote e-voting and voting at 28th Annual General 6. to Authorize Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company 7. to recommend the increase in remuneration of Mr. Sanjay Sethi (DIN: 00090277), Managing Director of the Company |
| 12 11 2021 | Quarterly Results |
| 11 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results (Revised) |
| 09 08 2022 | Quarterly Results |
| 02 09 2022 | A.G.M. |
| 14 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 25 08 2023 | A.G.M. |
| 08 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 20 04 2024 | Inter alia, to consider, approve :- 1. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP-1 for the year ended 2024-2025 2. To consider and approve the appointment of Abhay Bhandari & Associates, Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-2025. 3. To consider and approve the appointment of Dipika Kataria, Practicing Company Secretary as Secretarial Auditor of the Company for the year 2024-2025 4. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2024-2025 |
| 13 11 2024 | Quarterly Results |
| 08 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 07 08 2025 | Quarterly Results |
| 02 09 2025 | A.G.M. |
| 13 11 2025 | Quarterly Results |
| 03 01 2026 | Inter alia, to consider and approve the following matters: 1. To consider and approve the Appointment of Shailendra Pathak as an Additional Director subject to approval of shareholders in general meeting. 2. To consider and approve the Appointment of Mrs. Neha Sharda as an Independent Director subject to approval of shareholders in general meeting. 3. To consider and approve related party transaction with Aminova Infusions P. Ltd. subject to approval of shareholders in general meeting. 4. To consider and approve the resignation of Mrs. Neha Sharma from post of Company Secretary. 5. To consider and approve appointment of Mr. Kamlesh Gupta as the Company Secretary. 6. To consider and approve the date of holding EOGM. 7. Any other matter with the permission of the Chair. |
| 09 02 2026 | Quarterly Results |
| 01 04 2026 | Inter alia, to consider following business: - 1. To consider and approve the date and Notice of Extra Ordinary General Meeting (EOGM) for regularizing the appointment of Mr. Shailendra Pathak as the Whole Time Director of the Company and fixing his role, obligations and responsibilities and remuneration and for the appointment of Mrs. Neha Sarda as an Independent Director and for approval for material Related Party Transactions with M/s. - Aminova Infusions P. Ltd. where Mr. Shailendra Pathak is a director holding 50% equity. 2. Tofix the Cut-off Date and Remote E-voting period for Extra Ordinary General Meeting of the Company 3. To appoint Dipika Kataria as Scrutinizer for the purpose of remote e-voting and voting at EOGM of the Company 4. To Authorize Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company - 5. To consider and approve the appointment of Abhay Bhandari & Associates, Chartered Accountants as Internal Auditor of the Company for the Financial Year 2026-2027. 6. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP- 1 for the year ended 2026-2027 7. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2026-2027 8. To consider any other resolutions with the permission of the chair. |
News
No News data available
